Cargando…

Screening‐based identification of xanthone as a novel NLRP3 inflammasome inhibitor via metabolic reprogramming

Detalles Bibliográficos
Autores principales: Cui, Wenyu, Chen, Sheng, Chi, Zhexu, Guo, Xingchen, Zhang, Xiaobo, Zhong, Yueyang, Han, Haijie, Yao, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288006/
https://www.ncbi.nlm.nih.gov/pubmed/34323410
http://dx.doi.org/10.1002/ctm2.496
_version_ 1783724015996633088
author Cui, Wenyu
Chen, Sheng
Chi, Zhexu
Guo, Xingchen
Zhang, Xiaobo
Zhong, Yueyang
Han, Haijie
Yao, Ke
author_facet Cui, Wenyu
Chen, Sheng
Chi, Zhexu
Guo, Xingchen
Zhang, Xiaobo
Zhong, Yueyang
Han, Haijie
Yao, Ke
author_sort Cui, Wenyu
collection PubMed
description
format Online
Article
Text
id pubmed-8288006
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82880062021-07-21 Screening‐based identification of xanthone as a novel NLRP3 inflammasome inhibitor via metabolic reprogramming Cui, Wenyu Chen, Sheng Chi, Zhexu Guo, Xingchen Zhang, Xiaobo Zhong, Yueyang Han, Haijie Yao, Ke Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2021-07-19 /pmc/articles/PMC8288006/ /pubmed/34323410 http://dx.doi.org/10.1002/ctm2.496 Text en © 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to Editor
Cui, Wenyu
Chen, Sheng
Chi, Zhexu
Guo, Xingchen
Zhang, Xiaobo
Zhong, Yueyang
Han, Haijie
Yao, Ke
Screening‐based identification of xanthone as a novel NLRP3 inflammasome inhibitor via metabolic reprogramming
title Screening‐based identification of xanthone as a novel NLRP3 inflammasome inhibitor via metabolic reprogramming
title_full Screening‐based identification of xanthone as a novel NLRP3 inflammasome inhibitor via metabolic reprogramming
title_fullStr Screening‐based identification of xanthone as a novel NLRP3 inflammasome inhibitor via metabolic reprogramming
title_full_unstemmed Screening‐based identification of xanthone as a novel NLRP3 inflammasome inhibitor via metabolic reprogramming
title_short Screening‐based identification of xanthone as a novel NLRP3 inflammasome inhibitor via metabolic reprogramming
title_sort screening‐based identification of xanthone as a novel nlrp3 inflammasome inhibitor via metabolic reprogramming
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288006/
https://www.ncbi.nlm.nih.gov/pubmed/34323410
http://dx.doi.org/10.1002/ctm2.496
work_keys_str_mv AT cuiwenyu screeningbasedidentificationofxanthoneasanovelnlrp3inflammasomeinhibitorviametabolicreprogramming
AT chensheng screeningbasedidentificationofxanthoneasanovelnlrp3inflammasomeinhibitorviametabolicreprogramming
AT chizhexu screeningbasedidentificationofxanthoneasanovelnlrp3inflammasomeinhibitorviametabolicreprogramming
AT guoxingchen screeningbasedidentificationofxanthoneasanovelnlrp3inflammasomeinhibitorviametabolicreprogramming
AT zhangxiaobo screeningbasedidentificationofxanthoneasanovelnlrp3inflammasomeinhibitorviametabolicreprogramming
AT zhongyueyang screeningbasedidentificationofxanthoneasanovelnlrp3inflammasomeinhibitorviametabolicreprogramming
AT hanhaijie screeningbasedidentificationofxanthoneasanovelnlrp3inflammasomeinhibitorviametabolicreprogramming
AT yaoke screeningbasedidentificationofxanthoneasanovelnlrp3inflammasomeinhibitorviametabolicreprogramming